William Plovanic
Stock Analyst at Canaccord Genuity
(3.68)
# 798
Out of 5,131 analysts
168
Total ratings
49.66%
Success rate
7.4%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 → $35 | $21.35 | +63.93% | 7 | Dec 17, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $147 → $148 | $134.66 | +9.91% | 9 | Dec 17, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 → $12 | $5.89 | +103.91% | 5 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $89 → $87 | $83.01 | +4.81% | 30 | Dec 17, 2025 | |
| CBLL CeriBell | Maintains: Buy | $29 → $30 | $23.43 | +28.04% | 5 | Dec 17, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $132 → $131 | $95.72 | +36.86% | 13 | Dec 17, 2025 | |
| PODD Insulet | Maintains: Buy | $428 → $432 | $278.55 | +55.09% | 7 | Nov 24, 2025 | |
| HTFL HeartFlow | Maintains: Buy | $39 → $40 | $31.79 | +25.83% | 3 | Nov 13, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $51 | $42.89 | +18.91% | 4 | Nov 7, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $9 → $11 | $7.31 | +50.48% | 9 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $193 → $212 | $168.99 | +25.45% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $106 → $99 | $70.98 | +39.48% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $64 | $37.64 | +70.03% | 12 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $10.18 | +76.82% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.98 | +253.54% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $91.72 | -1.88% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $91.45 | +10.44% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.75 | +93.55% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $319.47 | -11.10% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $17.59 | +42.13% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.99 | +503.02% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $83.25 | -15.92% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $22.01 | +118.08% | 5 | Aug 3, 2023 |
Tandem Diabetes Care
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $21.35
Upside: +63.93%
TransMedics Group
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $134.66
Upside: +9.91%
TriSalus Life Sciences
Dec 17, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $5.89
Upside: +103.91%
Edwards Lifesciences
Dec 17, 2025
Maintains: Hold
Price Target: $89 → $87
Current: $83.01
Upside: +4.81%
CeriBell
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $23.43
Upside: +28.04%
Boston Scientific
Dec 17, 2025
Maintains: Buy
Price Target: $132 → $131
Current: $95.72
Upside: +36.86%
Insulet
Nov 24, 2025
Maintains: Buy
Price Target: $428 → $432
Current: $278.55
Upside: +55.09%
HeartFlow
Nov 13, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $31.79
Upside: +25.83%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $42.89
Upside: +18.91%
CVRx, Inc.
Nov 6, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $7.31
Upside: +50.48%
Oct 31, 2025
Maintains: Buy
Price Target: $193 → $212
Current: $168.99
Upside: +25.45%
Oct 31, 2025
Maintains: Buy
Price Target: $106 → $99
Current: $70.98
Upside: +39.48%
Oct 30, 2025
Maintains: Buy
Price Target: $53 → $64
Current: $37.64
Upside: +70.03%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $10.18
Upside: +76.82%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.98
Upside: +253.54%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $91.72
Upside: -1.88%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $91.45
Upside: +10.44%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.75
Upside: +93.55%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $319.47
Upside: -11.10%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $17.59
Upside: +42.13%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.99
Upside: +503.02%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $83.25
Upside: -15.92%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $22.01
Upside: +118.08%